Location History:
- Yamaguchi, JP (2021)
- Ube, JP (2022)
Company Filing History:
2 out of 86 
2 out of 259 
Years Active: 2021-2022
Title: Hiroaki Nagano: Pioneering Advancements in Therapeutic Prediction and Hybridization Techniques
Introduction
Hiroaki Nagano is an innovative inventor based in Ube, Japan. With a total of two patents to his name, Nagano has made significant contributions to the fields of therapeutic medicine and molecular biology.
Latest Patents
Two of Nagano's most recent patents showcase his expertise in predictive methodologies and hybridization techniques. The first patent entitled "Method for predicting therapeutic effects of irinotecan, and kit for same" utilizes a predetermined genetic polymorphism to forecast the efficacy of irinotecan treatment. This method involves analyzing a genetic polymorphism identified by rs1980576 in the APCDD1L gene, allowing for determination based on the genotype of the polymorphism.
His second patent focuses on hybridization, titled "Buffer composition for hybridization and hybridization method." This invention enhances the detection efficiency of target nucleic acids by employing a blocking nucleic acid to prevent non-specific hybridization. The buffer composition is designed to maintain a concentration of blocking nucleic acid that is higher than that of the nucleic acids in the mixture, optimizing the hybridization process for more accurate results.
Career Highlights
Throughout his career, Hiroaki Nagano has collaborated with reputable organizations such as Yamaguchi University and Toyo Kohan Co., Ltd. His work in these institutions has allowed him to explore new frontiers in medical technology and biotechnology.
Collaborations
Nagano has worked alongside colleagues Ryouichi Tsunedomi and Shoichi Hazama, contributing to a collaborative environment focused on innovation and research. Their combined efforts have advanced the understanding of therapeutic effects and molecular interactions.
Conclusion
Hiroaki Nagano's contributions to the fields of medical therapy and biotechnology through his patents demonstrate his commitment to innovation. With his advanced methods for predicting therapeutic outcomes and enhancing hybridization techniques, Nagano is helping to pave the way for future advancements in these critical areas of research. The impact of his work can lead to improved patient outcomes and a deeper understanding of genetic factors in treatment efficacy.